Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2740]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Expert overview of hot news in lymphoma from ASH 2012 (2/2)
Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (2/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012
Multiple myeloma advances for the future suggested by phase I clinical research
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Multiple myeloma advances for the future suggested by phase I clinical research ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012
Neurocognitive impact in adjuvant chemotherapy for breast cancer
Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor...
Neurocognitive impact in adjuvant chemotherapy for breast cancer ( Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA )
17 Dec 2012
Eribulin fails to demonstrate superiority over capecitabine in advanced breast...
Dr Peter Kaufman – Norris-Cotton Cancer Center, Lebanon, USA
Eribulin fails to demonstrate superiority over capecitabine in advanced breast cancer ( Dr Peter Kaufman – Norris-Cotton Cancer Center, Lebanon, USA )
16 Dec 2012
Results of the TACT2 and BEATRICE breast cancer trials
Prof David Cameron – Edinburgh University, UK
Results of the TACT2 and BEATRICE breast cancer trials ( Prof David Cameron – Edinburgh University, UK )
16 Dec 2012
Diverse genetic alterations found in triple-negative breast cancers after...
Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA
Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemo ( Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA )
16 Dec 2012
HDAC inhibition sensitises triple-negative breast cancer cells to PARP...
Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
13 Dec 2012
The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab
Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston...
The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab ( Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston, USA )
13 Dec 2012
Neratinib shows beneficial effects in the treatment of HER2 mutated breast...
Prof Ron Bose – Washington University School of Medicine, St. Louis, USA
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )
12 Dec 2012
Adjuvant chemotherapy for locally recurrent breast cancer
Dr Stefan Aebi – Luzerner Kantonsspital, Switzerland
Adjuvant chemotherapy for locally recurrent breast cancer ( Dr Stefan Aebi – Luzerner Kantonsspital, Switzerland )
12 Dec 2012
Effectiveness of sentinel lymph node surgery after chemotherapy in node...
Dr Judy Boughey – Mayo Clinic, Rochester USA
Effectiveness of sentinel lymph node surgery after chemotherapy in node-positive breast cancer ( Dr Judy Boughey – Mayo Clinic, Rochester USA )
12 Dec 2012
Extending adjuvant trastuzumab treatment time provided no additional benefit
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Extending adjuvant trastuzumab treatment time provided no additional benefit ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
12 Dec 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation